View in EDS HTML Full Text PDF Full Text

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment.

Saved in:
Bibliographic Details
Title: Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment.
Authors: Munroe ES; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan, United States of America., Grandits GA; Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America., Hyzy RC; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan, United States of America., Prescott HC; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.; VA Center for Clinical Management Research, Ann Arbor, Michigan, United States of America., Barrett TW; VA Portland Health Care System, and the Department of Medicine, Oregon Health & Science University, Portland, Oregon, United States of America., Dewar RL; Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Engen N; Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America., Goodman AL; MRC Clinical Trials Unit, University College London, London, United Kingdom.; Centre for Clinical Infection and Diagnostics Research at King's College London and Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Hatlen TJ; Division of HIV Medicine, Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, United States of America., Highbarger H; Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Holland TL; Department of Medicine, Division of Infectious Diseases, Duke University, Durham, North Carolina, United States of America.; Duke Clinical Research Institute, Durham, North Carolina, United States of America., Hughes G; MRC Clinical Trials Unit, University College London, London, United Kingdom., Jensen TO; Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Denmark., Khan MA; Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Kalomenidis I; 1st Department of Critical Care and Pulmonary Medicine, National and Kapodistrian University of Athens, School of Medicine, Evaggelismos Hospital, Athens, Greece., Kang N; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Laverdure S; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, Frederick, Maryland, United States of America., Manian P; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America., Menon V; Department of Medicine, New York City Health and Hospitals, Bronx, New York, United States of America., Patel R; V.A. Bay Pines Health Care System, Florida, United States., Ramachandruni S; Christus Spohn Hospital, Corpus Christi, Texas, United States of America., Rehman T; Leidos Biomedical Research Inc., Frederick, Maryland, United States of America., Shaw-Saliba K; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America., Røge BT; Department of Internal Medicine, Lillebælt Hospital, Kolding, Denmark., Vock DM; Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America., Weintrob AC; Infectious Diseases Section, Washington Veterans Affairs Medical Center, Washington, DC, United States of America., Young BE; National Centre for Infectious Diseases, Singapore., Frosch AP; Department of Medicine, Hennepin Healthcare Research Institute, University of Minnesota, Minneapolis, Minnesota, United States of America.
Corporate Authors: STRIVE Network and Therapeutics for Inpatients with COVID-19 (TICO) study groups
Source: PloS one [PLoS One] 2025 Jun 18; Vol. 20 (6), pp. e0325561. Date of Electronic Publication: 2025 Jun 18 (Print Publication: 2025).
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40531973
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Munroe+ES%22">Munroe ES</searchLink>; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.<br /><searchLink fieldCode="AU" term="%22Grandits+GA%22">Grandits GA</searchLink>; Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.<br /><searchLink fieldCode="AU" term="%22Hyzy+RC%22">Hyzy RC</searchLink>; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.<br /><searchLink fieldCode="AU" term="%22Prescott+HC%22">Prescott HC</searchLink>; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.; VA Center for Clinical Management Research, Ann Arbor, Michigan, United States of America.<br /><searchLink fieldCode="AU" term="%22Barrett+TW%22">Barrett TW</searchLink>; VA Portland Health Care System, and the Department of Medicine, Oregon Health & Science University, Portland, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Dewar+RL%22">Dewar RL</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Engen+N%22">Engen N</searchLink>; Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.<br /><searchLink fieldCode="AU" term="%22Goodman+AL%22">Goodman AL</searchLink>; MRC Clinical Trials Unit, University College London, London, United Kingdom.; Centre for Clinical Infection and Diagnostics Research at King's College London and Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hatlen+TJ%22">Hatlen TJ</searchLink>; Division of HIV Medicine, Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Highbarger+H%22">Highbarger H</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Holland+TL%22">Holland TL</searchLink>; Department of Medicine, Division of Infectious Diseases, Duke University, Durham, North Carolina, United States of America.; Duke Clinical Research Institute, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Hughes+G%22">Hughes G</searchLink>; MRC Clinical Trials Unit, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jensen+TO%22">Jensen TO</searchLink>; Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Khan+MA%22">Khan MA</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Kalomenidis+I%22">Kalomenidis I</searchLink>; 1st Department of Critical Care and Pulmonary Medicine, National and Kapodistrian University of Athens, School of Medicine, Evaggelismos Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Kang+N%22">Kang N</searchLink>; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Laverdure+S%22">Laverdure S</searchLink>; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Manian+P%22">Manian P</searchLink>; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Menon+V%22">Menon V</searchLink>; Department of Medicine, New York City Health and Hospitals, Bronx, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Patel+R%22">Patel R</searchLink>; V.A. Bay Pines Health Care System, Florida, United States.<br /><searchLink fieldCode="AU" term="%22Ramachandruni+S%22">Ramachandruni S</searchLink>; Christus Spohn Hospital, Corpus Christi, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Rehman+T%22">Rehman T</searchLink>; Leidos Biomedical Research Inc., Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Shaw-Saliba+K%22">Shaw-Saliba K</searchLink>; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Røge+BT%22">Røge BT</searchLink>; Department of Internal Medicine, Lillebælt Hospital, Kolding, Denmark.<br /><searchLink fieldCode="AU" term="%22Vock+DM%22">Vock DM</searchLink>; Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.<br /><searchLink fieldCode="AU" term="%22Weintrob+AC%22">Weintrob AC</searchLink>; Infectious Diseases Section, Washington Veterans Affairs Medical Center, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Young+BE%22">Young BE</searchLink>; National Centre for Infectious Diseases, Singapore.<br /><searchLink fieldCode="AU" term="%22Frosch+AP%22">Frosch AP</searchLink>; Department of Medicine, Hennepin Healthcare Research Institute, University of Minnesota, Minneapolis, Minnesota, United States of America.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22STRIVE+Network+and+Therapeutics+for+Inpatients+with+COVID-19+%28TICO%29+study+groups%22">STRIVE Network and Therapeutics for Inpatients with COVID-19 (TICO) study groups</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2025 Jun 18; Vol. 20 (6), pp. e0325561. <i>Date of Electronic Publication: </i>2025 Jun 18 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40531973
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0325561
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0325561
    Titles:
      – TitleFull: Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Munroe ES
      – PersonEntity:
          Name:
            NameFull: Grandits GA
      – PersonEntity:
          Name:
            NameFull: Hyzy RC
      – PersonEntity:
          Name:
            NameFull: Prescott HC
      – PersonEntity:
          Name:
            NameFull: Barrett TW
      – PersonEntity:
          Name:
            NameFull: Dewar RL
      – PersonEntity:
          Name:
            NameFull: Engen N
      – PersonEntity:
          Name:
            NameFull: Goodman AL
      – PersonEntity:
          Name:
            NameFull: Hatlen TJ
      – PersonEntity:
          Name:
            NameFull: Highbarger H
      – PersonEntity:
          Name:
            NameFull: Holland TL
      – PersonEntity:
          Name:
            NameFull: Hughes G
      – PersonEntity:
          Name:
            NameFull: Jensen TO
      – PersonEntity:
          Name:
            NameFull: Khan MA
      – PersonEntity:
          Name:
            NameFull: Kalomenidis I
      – PersonEntity:
          Name:
            NameFull: Kang N
      – PersonEntity:
          Name:
            NameFull: Laverdure S
      – PersonEntity:
          Name:
            NameFull: Manian P
      – PersonEntity:
          Name:
            NameFull: Menon V
      – PersonEntity:
          Name:
            NameFull: Patel R
      – PersonEntity:
          Name:
            NameFull: Ramachandruni S
      – PersonEntity:
          Name:
            NameFull: Rehman T
      – PersonEntity:
          Name:
            NameFull: Shaw-Saliba K
      – PersonEntity:
          Name:
            NameFull: Røge BT
      – PersonEntity:
          Name:
            NameFull: Vock DM
      – PersonEntity:
          Name:
            NameFull: Weintrob AC
      – PersonEntity:
          Name:
            NameFull: Young BE
      – PersonEntity:
          Name:
            NameFull: Frosch AP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 06
              Text: 2025 Jun 18
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1932-6203
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: PloS one
              Type: main
ResultId 1